Amgen Expands R&D C-Suite As Reese Focuses On Technology, Bradner Leads R&D
Former Novartis Exec Rejoins Biopharma Industry
Amgen appointed R&D head David Reese as EVP and chief technology officer and recruited former Novartis executive Jay Bradner as EVP of R&D and chief scientific officer.
